CN111812329A - Antibody chip kit for quantitatively detecting multiple tumor markers - Google Patents
Antibody chip kit for quantitatively detecting multiple tumor markers Download PDFInfo
- Publication number
- CN111812329A CN111812329A CN202010739081.2A CN202010739081A CN111812329A CN 111812329 A CN111812329 A CN 111812329A CN 202010739081 A CN202010739081 A CN 202010739081A CN 111812329 A CN111812329 A CN 111812329A
- Authority
- CN
- China
- Prior art keywords
- qualitative
- area
- microspheres
- quantitative
- nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 30
- 239000004005 microsphere Substances 0.000 claims abstract description 139
- 238000001514 detection method Methods 0.000 claims abstract description 129
- 239000000439 tumor marker Substances 0.000 claims abstract description 43
- 239000002245 particle Substances 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 239000000758 substrate Substances 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000010408 sweeping Methods 0.000 claims description 11
- 102000053602 DNA Human genes 0.000 claims description 9
- 108020004414 DNA Proteins 0.000 claims description 9
- 230000031700 light absorption Effects 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000002105 nanoparticle Substances 0.000 claims description 6
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 6
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 108010036226 antigen CYFRA21.1 Proteins 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 238000002474 experimental method Methods 0.000 claims description 3
- 238000009434 installation Methods 0.000 claims description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 3
- 239000006249 magnetic particle Substances 0.000 claims description 3
- -1 polyethylene Polymers 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000004451 qualitative analysis Methods 0.000 claims description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Nanotechnology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention relates to an antibody chip kit for quantitatively detecting multiple tumor markers. The qualitative nano microspheres and the quantitative magnetic microspheres are combined together, qualitative and quantitative detection can be simultaneously carried out at one time, ultrasonic resonance driving and magnetic field control are combined, the qualitative detection and the quantitative detection can be distinguished, and the qualitative detection does not influence the quantitative detection due to low use amount of the qualitative detection, so that the operation is simple and the stability is good. Qualitative detection is carried out by using qualitative microspheres with different particle diameters, so that the accuracy is good, and the anti-interference capability is strong. The quantitative detection is used, and the independent treatment is not needed for each tumor marker, so that the applicability is good; in addition, the ultrasonic and magnetic field control structure can be disassembled for multiple use, and the economy is good.
Description
Technical Field
The invention relates to the field of medical detection, in particular to an antibody chip kit for quantitatively detecting multiple tumor markers and a manufacturing method thereof.
Background
Tumor markers (Tumor markers) are substances which are synthesized and released by Tumor cells or are increased by the body reacting to the Tumor cells, and the main components of the Tumor markers are proteins, saccharides and the like. The tumor marker exists in blood, body fluid and tissue, can be detected by methods such as biochemistry, immunology, genomics and the like, and can be used for early diagnosis, prognosis prediction, curative effect evaluation and the like of tumors. Abnormal elevation of tumor markers may indicate the occurrence of a tumor, but abnormal elevation of tumor markers may also occur in non-neoplastic diseases.
The existing tumor marker detection generally adopts a flow cytometry method, and researchers detect the tumor marker based on the technologies of fluorescent coding microspheres and the like at present, but the method can carry out quantitative detection only by independently setting corresponding detection reagents aiming at different tumor markers, and has the disadvantages of complex material treatment and large using amount. One detection needs to be provided with a reagent for quantitative detection for all tumor markers, but in actual detection, at most one or two markers can be detected. In addition, in actual detection, when rapid detection is required, other detection means such as CT are often combined, so that the concentration of the tumor marker can be determined only by detecting which type of the tumor marker is present.
Disclosure of Invention
Aiming at the content, the antibody chip kit for quantitatively detecting multiple tumor markers is provided for solving the problems, and comprises a microfluidic chip, an ultrasonic exciter, a magnetic controller, qualitative nano microspheres with different particle sizes, quantitative magnetic microspheres, a sulfhydryl luminescent group reagent, antibodies of multiple tumor markers and a fluorescence detector; the surface of each qualitative nano microsphere can be modified with an antibody of a tumor marker, and the surface of each qualitative nano microsphere can be modified with a sulfhydryl luminescent group; the surface of the quantitative magnetic nano microsphere is simultaneously modified with a plurality of tumor marker antibodies, and the quantitative magnetic particles have fluorescence or characteristic light absorption peaks;
the micro-fluidic chip comprises a sample adding area, a reaction area, a transportation area and a detection area; the sample adding area comprises a reagent sample adding area and a sample adding area, the sample adding area is connected with the reaction area, the reaction area is connected with the transportation area, the transportation area is provided with a slender transportation channel, the detection area is provided with a qualitative detection area and a quantitative detection area, the number of the qualitative detection areas is multiple, each qualitative detection area is connected to outlets of the transportation area, which are different from the reaction area in distance, and the quantitative detection area is arranged at the tail of the transportation area;
outlets in the elongated transport channel of the transport zone comprise a high outlet and a low outlet, wherein the low outlet is an outlet connected to the qualitative detection zone, the high outlet is an outlet connected to the quantitative detection zone, wherein the horizontal position of the high outlet is higher than that of the low outlet, and the vertical height of the transport channel of the transport zone is more than 20 times that of the nano-microspheres and the magnetic microspheres; the qualitative nanometer microspheres and the quantitative magnetic microspheres are transported from the reaction area to the detection area under the action of the ultrasonic exciter and the magnetic controller.
The ultrasonic exciter comprises an ultrasonic signal regulator and ultrasonic transduction pieces, the number of the ultrasonic transduction pieces is multiple, and each group of the ultrasonic signal regulator comprises two pieces; the ultrasonic energy conversion sheet is divided into transverse combined longitudinal groups, one group of longitudinal groups are arranged at the front end and the rear end in the same transport direction with the transport area, a plurality of groups of transverse groups are arranged at the two ends perpendicular to the transport direction of the transport area, openings connected with the qualitative detection area are arranged on the side face perpendicular to the transport direction of the transport area, and each opening connected with the qualitative detection area is provided with one group of transverse groups;
two energy conversion sheets of the longitudinal group form moving standing waves when working, the working frequency of the longitudinal group is a composite frequency, the working mode is a frequency sweeping working mode, and qualitative nano microspheres and quantitative magnetic microspheres are pushed to advance from a reaction area to a detection area; the working mode of the transverse group is single frequency, and qualitative nano microspheres corresponding to the resonance frequency are pushed into corresponding openings so as to enter a qualitative detection area;
the magnetic controller is arranged on the upper surface and the lower surface of the detection chip and used for controlling the quantitative magnetic microspheres to be positioned on the upper surface of the transportation channel during transportation, so that the quantitative detection area is prevented from entering, and the other end of the quantitative detection area is directly reached.
The fluorescence detector detects the fluorescence intensity in each qualitative detection area, and the qualitative analysis of the tumor marker is carried out on the sample according to the fluorescence intensity of different qualitative detection areas; the photodetector detects the fluorescence intensity change or the characteristic light absorption change in the quantitative detection area, and the tumor marker is quantitatively analyzed on the sample by combining the frequency sweeping frequency of the longitudinal group.
The manufacturing method of the antibody chip kit for quantitatively detecting a plurality of tumor markers is characterized by comprising the following steps:
manufacturing the micro-fluidic chip:
processing a substrate, an intermediate layer and a top plate by using femtosecond laser, wherein the substrate, the intermediate layer and the top plate are made of PMMA (polymethyl methacrylate), the number of the intermediate layer is two, a sample adding area, a reaction area, a transportation area and a detection through hole are processed in the intermediate layer by using the femtosecond laser, mounting grooves for mounting a transducer plate and a magnetic controller are processed on the substrate and the top plate, a sample adding hole of the sample adding area is processed on the top plate, a channel connected to a qualitative detection area is processed in the lower intermediate layer, a channel connected to a quantitative detection area is processed in the upper intermediate layer, and the substrate, the intermediate layer and the top plate are sealed and bonded in sequence;
installation of an ultrasonic exciter and an ultrasonic controller:
mounting an ultrasonic transducer plate on the microfluidic chip, fixing the ultrasonic transducer plate by using an elastic clamp, and connecting a lead of the transducer plate to an ultrasonic generator; mounting a magnetic controller on the microfluidic chip and connecting the magnetic controller to a power supply;
preparation of reagents:
using ready-made Fe3O4Nanoparticles, antibodies of a plurality of different tumor markers including AFP, CEA, CYFRA21-1, CA19-9, CA125, PSA, NSE, beta-HCG, etc.; the corresponding antibody is connected to Fe by using DNA or sulfhydrylation treatment3O4Obtaining quantitative magnetic microspheres from the nano particles;
using SiO of different particle sizes2The microsphere or polyethylene microsphere has particle sizes of 150nm, 200nm, 500nm, 700nm, 1100nm, etc., and has a particle size floating range of less than 5% as qualitative nanometer microsphere; and the surface of the qualitative nano microsphere is activated so that the qualitative nano microsphere can be connected with a sulfhydrylation fluorescent group.
During detection, each qualitative nano microsphere with different particle sizes is connected with an antibody of a tumor marker in a DNA (deoxyribonucleic acid) connection mode or a sulfhydrylation connection mode, and then the qualitative nano microspheres and the antibody are mixed to be modified by a fluorescent luminescent group; mixing the modified nano microspheres with quantitative magnetic microspheres in a mixing ratio of qualitative nano microspheres: the quantitative magnetic microspheres are 1:100 to 1:10000, so that the influence of qualitative detection on quantitative detection is reduced;
injecting the mixed microspheres into the sample adding hole, adding a sample to be detected into the sample adding hole, so that the mixed microspheres react with the sample to be detected, and combining the tumor marker with the qualitative nano microspheres and the quantitative magnetic microspheres, wherein the qualitative nano microspheres are completely reacted during reaction because the quantity of the qualitative nano microspheres is far lower than that of the quantitative magnetic microspheres;
starting the ultrasonic energy conversion sheets of the longitudinal group, and sweeping frequency to enable all the microspheres to move to a detection area along the transportation area; simultaneously starting the transverse group, wherein the vibration frequency of the transverse group is preset, so that the qualitative nano microspheres which are not connected with the tumor marker under the driving of the transverse group can enter the qualitative detection area from the corresponding openings, and the qualitative nano microspheres connected with the tumor marker cannot enter the qualitative detection area because the tumor marker changes the resonance frequency and cannot be driven by the corresponding transverse group; detecting the fluorescence intensity of different qualitative detection areas, wherein the qualitative detection area which can not detect the fluorescence intensity all the time indicates that the corresponding qualitative nano-microsphere detects the tumor marker;
the quantitative magnetic microspheres move along the transportation area under the driving of the longitudinal group, and meanwhile, the magnetic controller is started, so that the magnetic microspheres move along the top of the transportation area and can enter the quantitative detection area;
because the longitudinal group is in a frequency sweeping mode, the quantitative magnetic microspheres can be driven to move only by scanning the corresponding resonance frequency, so that the magnetic microspheres entering the quantitative detection area are increased in a pulse mode, the fluorescence or characteristic light absorption intensity of the magnetic microspheres in the quantitative detection area is caused to change intermittently, the resonance frequency for driving the quantitative magnetic microspheres can be obtained according to the time point of the intermittent change, the type of the tumor marker is obtained by qualitative detection, the concentration of the tumor marker combined on the surface of the quantitative magnetic microspheres can be reversely deduced according to the resonance frequency, and the influence of each tumor marker with different concentrations on the resonance frequency of the quantitative magnetic microspheres can be obtained in advance through experiments, and a standard curve or a table is drawn.
The invention has the beneficial effects that: the invention combines the qualitative nano microspheres and the quantitative magnetic microspheres, can simultaneously carry out qualitative and quantitative detection at one time, uses the combination of ultrasonic resonance drive and magnetic field control, can distinguish the qualitative detection from the quantitative detection, has simple operation and good stability, and does not influence the quantitative detection due to the low use amount of the qualitative detection.
Qualitative detection is carried out by using qualitative microspheres with different particle diameters, so that the accuracy is good, and the anti-interference capability is strong. The quantitative detection is used, and the independent treatment is not needed for each tumor marker, so that the applicability is good; in addition, the ultrasonic and magnetic field control structure can be disassembled for multiple use, and the economy is good.
Drawings
The accompanying drawings, which are included to provide a further understanding of the disclosed subject matter, are incorporated in and constitute a part of this specification. The drawings illustrate the implementations of the disclosed subject matter and, together with the detailed description, serve to explain the principles of implementations of the disclosed subject matter. No attempt is made to show structural details of the disclosed subject matter in more detail than is necessary for a fundamental understanding of the disclosed subject matter and various modes of practicing the same.
Fig. 1 is a schematic structural diagram of a microfluidic chip according to the present invention.
Detailed Description
The advantages, features and methods of accomplishing the same will become apparent from the drawings and the detailed description that follows.
Example (b):
an antibody chip kit for quantitatively detecting multiple tumor markers comprises a microfluidic chip, an ultrasonic exciter, a magnetic controller, qualitative nano microspheres with different particle sizes, quantitative magnetic microspheres, a sulfhydryl luminescent group reagent, antibodies of multiple tumor markers and a fluorescence detector; the surface of each qualitative nano microsphere can be modified with an antibody of a tumor marker, and the surface of each qualitative nano microsphere can be modified with a sulfhydryl luminescent group; the surface of the quantitative magnetic nano microsphere is simultaneously modified with a plurality of tumor marker antibodies, and the quantitative magnetic particles have fluorescence or characteristic light absorption peaks;
the micro-fluidic chip comprises a sample adding area 11, a reaction area 12, a transportation area 13 and a detection area; the sample adding area 11 comprises a reagent sample adding area 11 and a sample adding area 11, the sample adding area 11 is connected with a reaction area 12, the reaction area 12 is connected with a transport area 13, the transport area 13 is provided with a slender transport channel, the detection area is provided with a qualitative detection area 14 and a quantitative detection area 15, the number of the qualitative detection areas 14 is multiple, each qualitative detection area 14 is connected with outlets of the transport area 13, which are different from the reaction area 12 in distance, and the quantitative detection area 15 is arranged at the tail end of the transport area 13;
the outlets in the elongated transport channel of the transport zone 13 comprise a high outlet and a low outlet, wherein the low outlet is an outlet connected to the qualitative detection zone 14 and the high outlet is an outlet connected to the quantitative detection zone 15, wherein the horizontal position of the high outlet is higher than the horizontal position of the low outlet, and the vertical height of the transport channel of the transport zone 13 is more than 20 times that of the nano-microspheres and the magnetic microspheres; the qualitative nano-microspheres and the quantitative magnetic microspheres are transported from the reaction zone 12 to the detection zone under the action of the ultrasonic exciter and the magnetic controller.
The ultrasonic exciter comprises an ultrasonic signal adjuster and ultrasonic transducer plates 16, the number of the ultrasonic transducer plates 16 is multiple, and each group of the ultrasonic transducer plates 16 comprises two plates; the ultrasonic transducer 16 is divided into transverse combined longitudinal groups, one group of longitudinal groups is arranged at the front end and the rear end in the same transport direction as the transport area 13, a plurality of groups of transverse groups are arranged at the two ends perpendicular to the transport direction of the transport area 13, openings connected with the qualitative detection area 14 are arranged on the side face perpendicular to the transport direction of the transport area 13, and each opening connected with the qualitative detection area 14 is provided with one group of transverse groups;
when the two energy conversion sheets of the longitudinal group work, a moving standing wave is formed, the working frequency of the longitudinal group is a composite frequency, the working mode is a frequency sweeping working mode, and qualitative nano microspheres and quantitative magnetic microspheres are pushed to move forward from the reaction area 12 to the detection area; the transverse group operates at a single frequency to push the qualitative nanospheres corresponding to the resonant frequency into the corresponding openings 18 and thus into the qualitative detection zone 14;
the magnetic controller 17 is arranged on the upper surface and the lower surface of the detection chip, controls the quantitative magnetic microspheres to be positioned on the upper surface of the transportation channel during transportation, and avoids entering the qualitative detection area 14, so that the other end of the quantitative magnetic microspheres directly reaching the transportation area 13 enters the quantitative detection area 15.
The fluorescence detector detects the fluorescence intensity in each qualitative detection area 14, and the tumor marker is qualitatively analyzed for the sample according to the fluorescence intensity of different qualitative detection areas 14; the photodetector detects the change of fluorescence intensity or the change of characteristic light absorption in the quantitative detection area 15, and the tumor marker is quantitatively analyzed on the sample by combining the frequency sweeping frequency of the longitudinal group.
The manufacturing method of the antibody chip kit for quantitatively detecting a plurality of tumor markers is characterized by comprising the following steps:
manufacturing the micro-fluidic chip:
processing a substrate, an intermediate layer and a top plate by using femtosecond laser, wherein the substrate, the intermediate layer and the top plate are made of PMMA (polymethyl methacrylate), the number of the intermediate layer is two, a sample adding area 11, a reaction area 12, a transportation area 13 and a detection through hole are processed in the intermediate layer by using the femtosecond laser, mounting grooves for mounting a transducer plate and a magnetic controller 17 are processed in the substrate and the top plate, a sample adding hole of the sample adding area 11 is processed in the top plate, a channel connected to a qualitative detection area 14 is processed in the lower intermediate layer, a channel connected to a quantitative detection area 15 is processed in the upper intermediate layer, and the substrate, the intermediate layer and the top plate are sealed and bonded in sequence;
installation of an ultrasonic exciter and an ultrasonic controller:
mounting the ultrasonic transducer plate 16 on the microfluidic chip and fixing the plate by using an elastic clamp, and connecting the lead of the transducer plate to an ultrasonic generator; mounting the magnetic controller 17 on the microfluidic chip and connecting the magnetic controller 17 to a power supply;
preparation of reagents:
using ready-made Fe3O4Nanoparticles, antibodies of a plurality of different tumor markers including AFP, CEA, CYFRA21-1, CA19-9, CA125, PSA, NSE, beta-HCG, etc.; the corresponding antibody is connected to Fe by using DNA or sulfhydrylation treatment3O4Obtaining quantitative magnetic microspheres from the nano particles;
using SiO of different particle sizes2The microsphere or polyethylene microsphere has particle sizes of 150nm, 200nm, 500nm, 700nm, 1100nm, etc., and has a particle size floating range of less than 5% as qualitative nanometer microsphere; and the surface of the qualitative nano microsphere is activated so that the qualitative nano microsphere can be connected with a sulfhydrylation fluorescent group.
During detection, each qualitative nano microsphere with different particle sizes is connected with an antibody of a tumor marker in a DNA (deoxyribonucleic acid) connection mode or a sulfhydrylation connection mode, and then the qualitative nano microspheres and the antibody are mixed to be modified by a fluorescent luminescent group; mixing the modified nano microspheres with quantitative magnetic microspheres in a mixing ratio of qualitative nano microspheres: the quantitative magnetic microspheres are 1:100 to 1:10000, so that the influence of qualitative detection on quantitative detection is reduced;
injecting the mixed microspheres into the sample adding hole, adding a sample to be detected into the sample adding hole, so that the mixed microspheres react with the sample to be detected, and combining the tumor marker with the qualitative nano microspheres and the quantitative magnetic microspheres, wherein the qualitative nano microspheres are completely reacted during reaction because the quantity of the qualitative nano microspheres is far lower than that of the quantitative magnetic microspheres;
starting the longitudinal groups of ultrasonic transducers 16, and sweeping the frequency so that all the microspheres move along the transport zone 13 to the detection zone; simultaneously starting the transverse group, wherein the vibration frequency of the transverse group is preset, so that the qualitative nano microspheres which are not connected with the tumor marker under the driving of the transverse group can enter the qualitative detection region 14 from the corresponding openings, and the qualitative nano microspheres connected with the tumor marker cannot enter the qualitative detection region 14 because the tumor marker changes the resonance frequency and cannot be driven by the corresponding transverse group; at this time, the fluorescence intensities of the different qualitative detection areas 14 are detected, and the qualitative detection area 14 in which the fluorescence intensities are not detected all the time indicates that the tumor marker is detected by the corresponding qualitative nano-microsphere;
the quantitative magnetic microspheres move along the transportation area 13 under the driving of the longitudinal group, and meanwhile, the magnetic controller 17 is started, so that the magnetic microspheres move along the top of the transportation area 13 and can enter the quantitative detection area 15;
because the longitudinal group is in a frequency sweeping mode, the quantitative magnetic microspheres can be driven to move only by scanning to the corresponding resonance frequency, so that the magnetic microspheres entering the quantitative detection area 15 are increased in a pulse mode, the fluorescence or characteristic light absorption intensity of the magnetic microspheres in the quantitative detection area 15 is intermittently changed, the resonance frequency for driving the quantitative magnetic microspheres can be obtained according to the time point of the intermittent change, the tumor markers can be obtained by qualitative detection, the concentration of the tumor markers combined on the surface of the quantitative magnetic microspheres can be reversely deduced according to the resonance frequency, the influence of each tumor marker with different concentrations on the resonance frequency of the quantitative magnetic microspheres can be obtained by experiments in advance, and a standard curve or a table can be drawn.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (5)
1. An antibody chip kit for quantitatively detecting multiple tumor markers is characterized by comprising a microfluidic chip, an ultrasonic exciter, a magnetic controller, qualitative nano-microspheres with different particle sizes, quantitative magnetic microspheres, a sulfhydryl luminescent group reagent, antibodies of multiple tumor markers and a fluorescence detector; the surface of each qualitative nano microsphere can be modified with an antibody of a tumor marker, and the surface of each qualitative nano microsphere can be modified with a sulfhydryl luminescent group; the surface of the quantitative magnetic nano microsphere is simultaneously modified with a plurality of tumor marker antibodies, and the quantitative magnetic particles have fluorescence or characteristic light absorption peaks;
the micro-fluidic chip comprises a sample adding area (11), a reaction area (12), a transportation area (13) and a detection area; the sample adding area (11) comprises a reagent sample adding area (11) and a sample adding area (11), the sample adding area (11) is connected with the reaction area (12), the reaction area (12) is connected with the transportation area (13), the transportation area (13) is provided with a slender transportation channel, the detection area is provided with a qualitative detection area (14) and a quantitative detection area (15), the number of the qualitative detection areas (14) is multiple, each qualitative detection area (14) is connected to outlets of the transportation area (13) which are different in distance from the reaction area (12), and the quantitative detection area (15) is arranged at the tail of the transportation area (13);
the outlet in the elongated transport channel of the transport zone (13) comprises a high outlet and a low outlet, wherein the low outlet is an outlet connected to the qualitative detection zone (14) and the high outlet is an outlet connected to the quantitative detection zone (15), wherein the horizontal position of the high outlet is higher than the horizontal position of the low outlet, and the vertical height of the transport channel of the transport zone (13) is more than 20 times that of the nano-microspheres and the magnetic microspheres; the qualitative nano-microspheres and the quantitative magnetic microspheres are transported from the reaction zone (12) to the detection zone under the action of the ultrasonic exciter and the magnetic controller.
2. The antibody chip kit for quantitatively detecting multiple tumor markers according to claim 1, wherein:
the ultrasonic exciter comprises an ultrasonic signal adjuster and ultrasonic transducer plates (16), the number of the ultrasonic transducer plates (16) is multiple, and each group of the ultrasonic transducer plates comprises two plates; the ultrasonic energy conversion sheets (16) are divided into transverse combined longitudinal groups, one group of longitudinal groups are arranged at the front end and the rear end in the same transportation direction with the transportation area (13), a plurality of groups of transverse groups are arranged at the two ends perpendicular to the transportation direction of the transportation area (13), openings connected with the qualitative detection areas (14) are arranged on the side face perpendicular to the transportation direction of the transportation area (13), and one group of transverse groups is arranged at each opening connected with the qualitative detection area (14);
when the two energy conversion sheets of the longitudinal group work, a moving standing wave is formed, the working frequency of the longitudinal group is a composite frequency, the working mode is a frequency sweeping working mode, and the qualitative nano microspheres and the quantitative magnetic microspheres are pushed to move forward from the reaction area (12) to the detection area; the working mode of the transverse group is single frequency, and qualitative nano microspheres corresponding to the resonance frequency are pushed into the corresponding openings (18) so as to enter the qualitative detection area (14);
magnetic controller (17) sets up on the upper and lower surface of detecting the chip, and control quantitative magnetic microsphere is located the upper surface of transport passageway when the transportation, avoids getting into qualitative detection zone (14) to the other end that directly reaches transport zone (13) gets into quantitative detection zone (15).
3. The antibody chip kit for quantitatively detecting multiple tumor markers according to claim 2, wherein the fluorescence detector detects the fluorescence intensity in each qualitative detection area (14), and performs qualitative analysis of the tumor markers on the sample according to the fluorescence intensities of the different qualitative detection areas (14); the photodetector detects the change of fluorescence intensity or the change of characteristic light absorption in the quantitative detection area (15), and the tumor marker is quantitatively analyzed on the sample by combining the frequency sweeping frequency of the longitudinal group.
4. A method for preparing an antibody chip kit for quantitatively detecting multiple tumor markers as claimed in any one of claims 1 to 3, comprising the steps of:
manufacturing the micro-fluidic chip:
processing a substrate, an intermediate layer and a top plate by using femtosecond laser, wherein the substrate, the intermediate layer and the top plate are made of PMMA (polymethyl methacrylate), the number of the intermediate layer is two, a sample adding area (11), a reaction area (12), a transportation area (13) and a detection through hole are processed in the intermediate layer by using the femtosecond laser, mounting grooves for mounting a transducer and a magnetic controller (17) are processed in the substrate and the top plate, a sample adding hole of the sample adding area (11) is processed in the top plate, a channel connected to a qualitative detection area (14) is processed in the lower intermediate layer, a channel connected to a quantitative detection area (15) is processed in the upper intermediate layer, and the substrate, the intermediate layer and the top plate are sealed and bonded in sequence;
installation of an ultrasonic exciter and an ultrasonic controller:
mounting an ultrasonic transducer plate (16) on the microfluidic chip, fixing the ultrasonic transducer plate by using an elastic clamp, and connecting a lead of the transducer plate to an ultrasonic generator; mounting a magnetic controller (17) on the microfluidic chip and connecting the magnetic controller (17) to a power supply;
preparation of reagents:
using ready-made Fe3O4Nanoparticles, antibodies of a plurality of different tumor markers including AFP, CEA, CYFRA21-1, CA19-9, CA125, PSA, NSE, beta-HCG, etc.; the corresponding antibody is connected to Fe by using DNA or sulfhydrylation treatment3O4Obtaining quantitative magnetic microspheres from the nano particles;
using SiO of different particle sizes2The microsphere or polyethylene microsphere has particle sizes of 150nm, 200nm, 500nm, 700nm, 1100nm, etc., and has a particle size floating range of less than 5% as qualitative nanometer microsphere; and the surface of the qualitative nano microsphere is activated so that the qualitative nano microsphere can be connected with a sulfhydrylation fluorescent group.
5. The method of manufacturing according to claim 4, wherein:
during detection, each qualitative nano microsphere with different particle sizes is connected with an antibody of a tumor marker in a DNA (deoxyribonucleic acid) connection mode or a sulfhydrylation connection mode, and then the qualitative nano microspheres and the antibody are mixed to be modified by a fluorescent luminescent group; mixing the modified nano microspheres with quantitative magnetic microspheres in a mixing ratio of qualitative nano microspheres: the quantitative magnetic microspheres are 1:100 to 1:10000, so that the influence of qualitative detection on quantitative detection is reduced;
injecting the mixed microspheres into the sample adding hole, adding a sample to be detected into the sample adding hole, so that the mixed microspheres react with the sample to be detected, and combining the tumor marker with the qualitative nano microspheres and the quantitative magnetic microspheres, wherein the qualitative nano microspheres are completely reacted during reaction because the quantity of the qualitative nano microspheres is far lower than that of the quantitative magnetic microspheres;
starting the longitudinal group of ultrasonic transducer plates (16) to sweep frequency, so that all microspheres move to a detection area along the transportation area (13); simultaneously starting the transverse group, wherein the vibration frequency of the transverse group is preset, so that the qualitative nano microspheres which are not connected with the tumor marker can enter the qualitative detection area (14) from the corresponding openings under the driving of the transverse group, and the qualitative nano microspheres which are connected with the tumor marker cannot enter the qualitative detection area (14) because the tumor marker changes the resonance frequency and cannot be driven by the corresponding transverse group; detecting the fluorescence intensity of different qualitative detection areas (14), wherein the qualitative detection area (14) which can not detect the fluorescence intensity all the time indicates that the corresponding qualitative nano-microsphere detects the tumor marker;
the quantitative magnetic microspheres move along the transportation area (13) under the driving of the longitudinal group, and meanwhile, a magnetic controller (17) is started, so that the magnetic microspheres move along the top of the transportation area (13) and can enter the quantitative detection area (15);
because the longitudinal group is in a frequency sweeping mode, the quantitative magnetic microspheres can be driven to move only by scanning the corresponding resonance frequency, so that the magnetic microspheres entering the quantitative detection area (15) are increased in a pulse mode, the fluorescence or characteristic light absorption intensity of the magnetic microspheres in the quantitative detection area (15) is caused to change intermittently, the resonance frequency for driving the quantitative magnetic microspheres can be obtained according to the time point of the intermittent change, the tumor marker type can be obtained by qualitative detection, the tumor marker concentration combined on the surface of the quantitative magnetic microspheres can be reversely deduced according to the resonance frequency, and the influence of each tumor marker with different concentrations on the resonance frequency of the quantitative magnetic microspheres can be obtained through experiments in advance and a standard curve or a table can be drawn.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010739081.2A CN111812329B (en) | 2020-07-28 | 2020-07-28 | Antibody chip kit for quantitatively detecting multiple tumor markers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010739081.2A CN111812329B (en) | 2020-07-28 | 2020-07-28 | Antibody chip kit for quantitatively detecting multiple tumor markers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111812329A true CN111812329A (en) | 2020-10-23 |
| CN111812329B CN111812329B (en) | 2023-03-10 |
Family
ID=72863217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010739081.2A Active CN111812329B (en) | 2020-07-28 | 2020-07-28 | Antibody chip kit for quantitatively detecting multiple tumor markers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111812329B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113075176A (en) * | 2021-03-17 | 2021-07-06 | 西安医学院 | Tumor marker multi-analysis device |
| CN113655218A (en) * | 2021-08-26 | 2021-11-16 | 台州安奇灵智能科技有限公司 | A Microfluidic Instant Immunoassay Based on Magnetic Nanoparticles |
| CN119322176A (en) * | 2024-12-17 | 2025-01-17 | 中国科学院杭州医学研究所 | Biochip for simultaneously detecting multiple abundance markers and application thereof |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030186465A1 (en) * | 2001-11-27 | 2003-10-02 | Kraus Robert H. | Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits |
| WO2003089157A1 (en) * | 2002-04-17 | 2003-10-30 | Cytonome, Inc. | Method and apparatus for sorting particles |
| US20080160630A1 (en) * | 2006-12-29 | 2008-07-03 | Intel Corporation | Enzymatic signal generation and detection of binding complexes in stationary fluidic chip |
| US20090053688A1 (en) * | 2007-08-20 | 2009-02-26 | Allied Innovative Systems, Llc | method and device for ultrasound assisted particle agglutination assay |
| WO2009082866A1 (en) * | 2007-12-29 | 2009-07-09 | Zhanke Wang | No limited flux magnetism microglobes quantitative detecting system and its use in biomedicine |
| US20110062957A1 (en) * | 2009-09-11 | 2011-03-17 | Hewlett-Packard Development Company, L.P. | Optically integrated biosensor based on optically detected magnetic resonance |
| US20150198532A1 (en) * | 2014-01-16 | 2015-07-16 | Korea Institute Of Science And Technology | Biomarker detecting probe capable of early detection and precise quantification and use thereof |
| CN106353497A (en) * | 2016-08-18 | 2017-01-25 | 东南大学 | Multi-tumor-marker detecting platform and method based on SERS detecting technology and micro-fluidic chip |
| CN107328931A (en) * | 2017-05-16 | 2017-11-07 | 中山大学 | A kind of quick continuous detection technique based on nano-probe and magnetic micro-nano granules |
| US20180258473A1 (en) * | 2015-11-10 | 2018-09-13 | Administracion General De La Comunidad Autonoma De Euskadi | Diagnostic methods and devices |
| CN208894245U (en) * | 2018-06-26 | 2019-05-24 | 宁波奥丞生物科技有限公司 | The micro-fluidic chip of rapid quantitative detection PLGF and sFLT-1 |
| CN111007265A (en) * | 2020-01-16 | 2020-04-14 | 郑州大学 | Simoa kit of preeclampsia risk prediction marker PIGF and application thereof |
-
2020
- 2020-07-28 CN CN202010739081.2A patent/CN111812329B/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030186465A1 (en) * | 2001-11-27 | 2003-10-02 | Kraus Robert H. | Apparatus used in identification, sorting and collection methods using magnetic microspheres and magnetic microsphere kits |
| WO2003089157A1 (en) * | 2002-04-17 | 2003-10-30 | Cytonome, Inc. | Method and apparatus for sorting particles |
| US20080160630A1 (en) * | 2006-12-29 | 2008-07-03 | Intel Corporation | Enzymatic signal generation and detection of binding complexes in stationary fluidic chip |
| US20090053688A1 (en) * | 2007-08-20 | 2009-02-26 | Allied Innovative Systems, Llc | method and device for ultrasound assisted particle agglutination assay |
| WO2009082866A1 (en) * | 2007-12-29 | 2009-07-09 | Zhanke Wang | No limited flux magnetism microglobes quantitative detecting system and its use in biomedicine |
| US20110062957A1 (en) * | 2009-09-11 | 2011-03-17 | Hewlett-Packard Development Company, L.P. | Optically integrated biosensor based on optically detected magnetic resonance |
| US20150198532A1 (en) * | 2014-01-16 | 2015-07-16 | Korea Institute Of Science And Technology | Biomarker detecting probe capable of early detection and precise quantification and use thereof |
| US20180258473A1 (en) * | 2015-11-10 | 2018-09-13 | Administracion General De La Comunidad Autonoma De Euskadi | Diagnostic methods and devices |
| CN106353497A (en) * | 2016-08-18 | 2017-01-25 | 东南大学 | Multi-tumor-marker detecting platform and method based on SERS detecting technology and micro-fluidic chip |
| CN107328931A (en) * | 2017-05-16 | 2017-11-07 | 中山大学 | A kind of quick continuous detection technique based on nano-probe and magnetic micro-nano granules |
| CN208894245U (en) * | 2018-06-26 | 2019-05-24 | 宁波奥丞生物科技有限公司 | The micro-fluidic chip of rapid quantitative detection PLGF and sFLT-1 |
| CN111007265A (en) * | 2020-01-16 | 2020-04-14 | 郑州大学 | Simoa kit of preeclampsia risk prediction marker PIGF and application thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113075176A (en) * | 2021-03-17 | 2021-07-06 | 西安医学院 | Tumor marker multi-analysis device |
| CN113075176B (en) * | 2021-03-17 | 2022-11-01 | 西安医学院 | Tumor Marker Multiplex Analysis Device |
| CN113655218A (en) * | 2021-08-26 | 2021-11-16 | 台州安奇灵智能科技有限公司 | A Microfluidic Instant Immunoassay Based on Magnetic Nanoparticles |
| CN119322176A (en) * | 2024-12-17 | 2025-01-17 | 中国科学院杭州医学研究所 | Biochip for simultaneously detecting multiple abundance markers and application thereof |
| CN119322176B (en) * | 2024-12-17 | 2025-03-25 | 中国科学院杭州医学研究所 | A biochip for simultaneous detection of multiple abundance markers and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111812329B (en) | 2023-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111812329B (en) | Antibody chip kit for quantitatively detecting multiple tumor markers | |
| AU2013279833B2 (en) | A method and a system for quantitative or qualitative determination of a target component | |
| WO2008094198A2 (en) | Devices and methods for performing receptor binding assays using magnetic particles | |
| CN1253625A (en) | Microfluidic devices incorporating improved channel geometries | |
| US20120225491A1 (en) | Portable detection devices and methods for detection of biomarkers and other analytes | |
| CN106353497A (en) | Multi-tumor-marker detecting platform and method based on SERS detecting technology and micro-fluidic chip | |
| CN111013677B (en) | Microfluidic chip, detection device and detection method | |
| EP2955508B1 (en) | Automatic analysis device | |
| US12487237B2 (en) | Methods and devices for detection of biological materials using electric field assisted rapid analyte capture | |
| US9606067B2 (en) | Biological assay sample analyzer | |
| CN1901997A (en) | System | |
| US7951610B2 (en) | Reaction method and reaction apparatus | |
| CN112595759B (en) | A Homogeneous Analysis Method Based on the Change of the State of Insulating Microspheres to Change the Resistance of Microchannels | |
| US20090263891A1 (en) | Device for analyzing samples including a gas evolving means | |
| EP1691925A1 (en) | System | |
| KR101337136B1 (en) | Droplet-based microfluidic system integrated with diaphragm feeder | |
| CN117571631B (en) | A chemical water quality analysis flow path based on microfluidics | |
| US9005453B2 (en) | Detection target substance detecting method, detection target substance detecting chip used in the method, and detection target substance detecting apparatus | |
| JPH03504043A (en) | Device for multiple simultaneous measurements of electrochemiluminescence phenomena | |
| EP3798615B1 (en) | Chemiluminescence analytical method and system and kit using same | |
| US20120156687A1 (en) | Nanoparticles with molecular recognition elements | |
| CN101349676B (en) | Method for monitoring small molecule and life macromolecule interaction by ultrasonic wave | |
| CN211603212U (en) | Cell in-vivo capturing system to be detected | |
| Gao et al. | Self‐Propelled Microrockets to Capture and Isolate Circulating Tumor Cells | |
| CN119375209A (en) | A microfluidic SERS acquisition system and method for airborne fungal disease spores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |